Companies / Healthtech
Biobank is a leading human tissue bank whose speciality lies in preparing and distributing bone allografts for orthopaedic, spinal, dental and CMF surgeries
Year
2018 / 2024
Status
Current
Team
Fund
Verto Growth I
& reinvestment with Verto Growth II
Key Facts
3
Money Multiple
1,700
Customers
50
Market Share in France
Verto partnered with Biobank with the objective of reinforcing its leadership in the French allograft market and accelerating its international development.
Under our ownership, Biobank consolidated its position as the French market leader, capturing over 50% market share, while significantly expanding its presence across Europe and key international markets. A major strategic step was the acquisition of Neutromedics, a leading Swiss distributor of allografts, which enabled deeper market penetration and supported the expansion of the distributor network into Belgium, Greece, Lebanon, Morocco, the United Kingdom, and Spain.
We also focused on driving organic growth, achieving a c.15% CAGR. To support this expansion, Biobank relocated to a new facility in Lieusaint, effectively doubling its production capacity and creating a scalable foundation for continued growth.
Operational and clinical capabilities were further enhanced through the recruitment of a Regulatory Affairs Manager and a Clinical Studies Manager, strengthening compliance, innovation, and efficiency across the business.
Verto exited Biobank and reinvested as minority shareholders in 2024.
All companies
